Sathiyasekar A, Chandrasekar P, Pakash A, Goma Kumar K, Jaishlal M
J Pharm Bioallied Sci. 2016; 8(Suppl 1):S8-S12.
PMID: 27829737
PMC: 5074047.
DOI: 10.4103/0975-7406.191974.
Nannegari V, Roque S, Rubin D, Quera R
Gastroenterol Hepatol (N Y). 2016; 10(10):626-30.
PMID: 27540334
PMC: 4988220.
Basra G, Basra S, Parupudi S
World J Hepatol. 2011; 3(5):118-20.
PMID: 21731904
PMC: 3124878.
DOI: 10.4254/wjh.v3.i5.118.
Verma S, Ajudia K, Mendler M, Redeker A
Dig Dis Sci. 2006; 51(9):1637-43.
PMID: 16927139
DOI: 10.1007/s10620-006-9099-z.
Pirisi M, Vitulli D, Falleti E, Fabris C, Soardo G, Del Forno M
J Clin Pathol. 1997; 50(1):50-3.
PMID: 9059357
PMC: 499713.
DOI: 10.1136/jcp.50.1.50.
Are HLA antigens important in the development of alcohol-induced liver disease?.
Faizallah R, Woodrow J, Krasner N, Walker R, Morris A
Br Med J (Clin Res Ed). 1982; 285(6341):533-4.
PMID: 6809159
PMC: 1499051.
DOI: 10.1136/bmj.285.6341.533.
Impaired monocyte function in liver cirrhosis.
Hassner A, Kletter Y, Shlag D, Yedvab M, Aronson M, SHIBOLET S
Br Med J (Clin Res Ed). 1981; 282(6272):1262-3.
PMID: 6784806
PMC: 1505383.
DOI: 10.1136/bmj.282.6272.1262.
Pathogenic mechanisms in primary biliary cirrhosis.
Thomas H, Epstein O
Springer Semin Immunopathol. 1980; 3(3):375-84.
PMID: 6455764
DOI: 10.1007/BF02054111.
Deficient natural killer cell activity in alcoholic cirrhosis.
Charpentier B, Franco D, Paci L, Charra M, Martin B, Vuitton D
Clin Exp Immunol. 1984; 58(1):107-15.
PMID: 6236915
PMC: 1576962.
Sensitisation to Mallory bodies (alcoholic hyalin) in alcoholic hepatitis.
Triggs S, Mills P, MacSween R
J Clin Pathol. 1981; 34(1):21-4.
PMID: 6161947
PMC: 1146402.
DOI: 10.1136/jcp.34.1.21.
Bacteremia in patients suffering from cirrhosis.
Almdal T, Skinhoj P, Friis H
Infection. 1986; 14(2):68-70.
PMID: 3710595
DOI: 10.1007/BF01644445.
Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.
Wagner F, Assemi C, Lersch C, Hart R, Classen M
Clin Exp Immunol. 1990; 82(2):344-9.
PMID: 2122935
PMC: 1535106.
DOI: 10.1111/j.1365-2249.1990.tb05450.x.
AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.
Pillai R, Nair B, Watson R
Arch Toxicol. 1991; 65(8):609-17.
PMID: 1747059
DOI: 10.1007/BF02098025.
T-lymphocyte activation pathways in alcoholic liver disease.
Spinozzi F, Bertotto A, Rondoni F, Gerli R, Scalise F, Grignani F
Immunology. 1991; 73(2):140-6.
PMID: 1676985
PMC: 1384456.
Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.
Naccarato R, Farinati F
Dig Dis Sci. 1991; 36(8):1137-42.
PMID: 1650691
DOI: 10.1007/BF01297461.
Suppressive effect of alcoholic liver disease sera on lymphocyte transformation.
Young G, DUDLEY F, van der Weyden M
Gut. 1979; 20(10):833-9.
PMID: 533694
PMC: 1412712.
DOI: 10.1136/gut.20.10.833.
Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis.
Snyder N, Bessoff J, Dwyer J, CONN H
Am J Dig Dis. 1978; 23(4):353-8.
PMID: 352138
DOI: 10.1007/BF01072420.
Inhibition of lymphocyte cytotoxicity by serum from patients with alcoholic liver disease: partial characterization of serum inhibitors.
Wands J, Dienstag J
Yale J Biol Med. 1978; 51(6):615-23.
PMID: 313125
PMC: 2595598.
Reduction in peripheral blood K cells and activated T cells in primary biliary cirrhosis.
Sandilands G, MacSween R, GRAY K, Holden R, Mills P, Reid F
Gut. 1977; 18(12):1017-20.
PMID: 304826
PMC: 1411832.
DOI: 10.1136/gut.18.12.1017.
The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity.
Thomas H, Singer C, Tilney N, Folch H, MacSween R
Clin Exp Immunol. 1976; 26(3):574-82.
PMID: 12899
PMC: 1540983.